Methiodal

CHEMBL2110978 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
222.0 g/mol
LogP
-0.1
Phase
4

A contrast agent formerly used in X-ray procedures to help visualize the urinary tract and other body cavities by making them appear more clearly on imaging. It has largely been replaced by safer, more modern contrast media.

น้ำหนักโมเลกุล

222.0000 g/mol

LogP

-0.10

TPSA

62.80 Ų

Lipinski RO5

ผ่าน

กลไกการออกฤทธิ์

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=S(=O)(O)CI

InChI

InChI=1S/CH3IO3S/c2-1-6(3,4)5/h1H2,(H,3,4,5)

Molecular Formula

CH3IO3S

HBD / HBA

1 / 3

พันธะที่หมุนได้

1

อะตอมหนัก

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A contrast agent formerly used in X-ray procedures to help visualize the urinary tract and other body cavities by making them appear more clearly on imaging. It has largely been replaced by safer, more modern contrast media.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Methiodal is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110978. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 31346. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.